Scaling Agents in Healthcare & Life Sciences: Lessons from Madrigal Pharmaceuticals, Abridge, and Vizient
From the source: LangChain Blog
Agent programs in healthcare and life sciences are being built under a different set of constraints than those in most industries. There’s plenty of upside if the constraints can be resolved. Success can mean hours of manual review compressed into minutes, data spread across a dozen systems finally queryable in one place, and clinicians getting time back from documentation. At the same time, the…
Read the full story on LangChain BlogAsk the square
The story is what was announced. If it raises a question for your team, ask the people who run this technology day to day. Your post links back to this story, so the next reader finds it too.
Recent threads in AI Agents & Automation
Which workflow did you automate with an AI agent first, and did it stick?
We are hearing a lot about agent pilots and far less about agents still running six months later. What was the first use case, what guardrails did you need, and is it still in production?
Build vs buy for internal AI agents: framework or platform?
LangGraph/CrewAI-style frameworks versus packaged agent platforms from the big vendors. If you have tried both, where did each win on time-to-value, control and cost?
Something wrong or out of date? Suggest a correction. We reply within 5 business days.
More from LangChain
Recent updates from LangChain, so you can tell whether this is a one-off or part of a pattern.
More in AI Agents & Automation
What other companies in AI Agents & Automation are doing. The category page shows who’s active, side by side.
